Clinical Trial Update: Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating glutamine combined with thalidomide to prevent radiation-induced oral mucositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Glutamine (glutamine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Mucositis Oral | Phase 3 | Status: COMPLETED